Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Stacey Bagby

Concepts (219)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Xenograft Model Antitumor Assays
24
2025
930
1.150
Why?
Colorectal Neoplasms
13
2025
848
1.100
Why?
Melanoma
9
2024
761
0.840
Why?
Antineoplastic Agents
13
2020
2197
0.730
Why?
Mice, Nude
16
2024
688
0.580
Why?
Carcinoma, Pancreatic Ductal
4
2024
292
0.520
Why?
Proto-Oncogene Proteins B-raf
4
2021
226
0.500
Why?
Protein Kinase Inhibitors
7
2020
970
0.470
Why?
Cell Line, Tumor
22
2024
3550
0.470
Why?
Drug Discovery
1
2016
155
0.450
Why?
Azepines
4
2024
107
0.450
Why?
Heterografts
4
2021
144
0.440
Why?
Triple Negative Breast Neoplasms
3
2024
216
0.420
Why?
Pyrimidines
4
2020
533
0.410
Why?
Adrenocortical Carcinoma
3
2020
67
0.410
Why?
Piperazines
4
2021
381
0.410
Why?
Tumor Microenvironment
4
2023
735
0.410
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2025
1958
0.400
Why?
Pancreatic Neoplasms
4
2024
927
0.380
Why?
Gene Expression Regulation, Neoplastic
8
2024
1462
0.380
Why?
Drug Resistance, Neoplasm
6
2024
883
0.350
Why?
Oncogene Proteins, Fusion
3
2018
211
0.350
Why?
Quinoxalines
3
2020
65
0.340
Why?
Histone Deacetylase Inhibitors
2
2024
220
0.340
Why?
Mice
28
2025
18365
0.340
Why?
Dasatinib
2
2024
57
0.340
Why?
Cell Proliferation
12
2024
2499
0.310
Why?
Disease Models, Animal
7
2022
4569
0.300
Why?
Neoplasms
5
2022
2884
0.270
Why?
Antibodies, Monoclonal, Humanized
3
2025
988
0.270
Why?
Adrenal Cortex Neoplasms
2
2020
65
0.270
Why?
Apoptosis
13
2024
2430
0.270
Why?
Animals
31
2025
38109
0.260
Why?
Pyridines
4
2022
605
0.250
Why?
Anilides
2
2018
84
0.240
Why?
Deoxycytidine
3
2024
221
0.240
Why?
Signal Transduction
10
2024
5233
0.230
Why?
CD47 Antigen
1
2025
42
0.230
Why?
Gene Regulatory Networks
2
2024
320
0.220
Why?
Proto-Oncogene Proteins
2
2018
623
0.200
Why?
Endogenous Retroviruses
1
2024
38
0.200
Why?
Bevacizumab
1
2024
167
0.200
Why?
Mucous Membrane
1
2024
127
0.200
Why?
Myeloid Cell Leukemia Sequence 1 Protein
2
2020
39
0.200
Why?
Benzimidazoles
1
2024
190
0.190
Why?
Camptothecin
3
2022
140
0.190
Why?
Lymphocytes, Tumor-Infiltrating
2
2020
154
0.180
Why?
NLR Family, Pyrin Domain-Containing 3 Protein
1
2023
169
0.180
Why?
Immunotherapy
3
2022
657
0.180
Why?
Wnt Signaling Pathway
2
2024
210
0.170
Why?
Fluorouracil
1
2022
235
0.170
Why?
beta Catenin
2
2020
253
0.170
Why?
MAP Kinase Kinase 1
1
2021
71
0.170
Why?
Cyclin-Dependent Kinase 4
1
2021
53
0.170
Why?
Cyclin-Dependent Kinase 6
1
2021
49
0.170
Why?
Transplantation, Heterologous
2
2022
194
0.160
Why?
Humans
40
2025
144957
0.160
Why?
Momordica charantia
1
2020
12
0.160
Why?
Aurora Kinase A
2
2020
62
0.160
Why?
Benzoxazoles
1
2020
20
0.160
Why?
Neoplasms, Experimental
2
2019
173
0.150
Why?
Immune System
1
2021
179
0.150
Why?
Adenine
2
2020
339
0.150
Why?
eIF-2 Kinase
1
2019
29
0.150
Why?
Biomarkers, Tumor
5
2021
1322
0.150
Why?
Aniline Compounds
1
2020
119
0.150
Why?
Pyrimidinones
2
2021
126
0.150
Why?
Mitogen-Activated Protein Kinase Kinases
1
2019
128
0.150
Why?
Tumor Cells, Cultured
4
2021
919
0.140
Why?
c-Mer Tyrosine Kinase
1
2018
38
0.140
Why?
Plant Extracts
1
2020
187
0.140
Why?
CDC2 Protein Kinase
1
2018
27
0.140
Why?
Pyridones
2
2021
199
0.140
Why?
Septins
1
2018
43
0.140
Why?
SOXB1 Transcription Factors
1
2018
67
0.140
Why?
Adrenal Cortex
1
2018
33
0.140
Why?
Oncogene Proteins v-abl
1
2017
5
0.130
Why?
Drug Synergism
2
2018
357
0.130
Why?
Programmed Cell Death 1 Receptor
1
2020
264
0.130
Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2018
40
0.130
Why?
Armadillo Domain Proteins
1
2017
6
0.130
Why?
src-Family Kinases
1
2017
93
0.130
Why?
Female
24
2025
78376
0.130
Why?
Skin Neoplasms
1
2024
847
0.130
Why?
Ubiquitin-Activating Enzymes
1
2016
20
0.120
Why?
Neoplasm Metastasis
2
2016
695
0.120
Why?
Cyclopentanes
1
2016
20
0.120
Why?
Proto-Oncogene Proteins c-ret
1
2017
41
0.120
Why?
Corynebacterium
1
2017
49
0.120
Why?
Corynebacterium Infections
1
2017
42
0.120
Why?
Cell Transformation, Neoplastic
1
2018
339
0.120
Why?
Tankyrases
1
2016
13
0.120
Why?
Sulfonamides
1
2020
581
0.120
Why?
G2 Phase Cell Cycle Checkpoints
3
2022
44
0.120
Why?
Autophagy
1
2018
286
0.120
Why?
MAP Kinase Kinase Kinases
1
2015
70
0.110
Why?
Mice, Inbred BALB C
3
2025
1253
0.110
Why?
TOR Serine-Threonine Kinases
2
2018
451
0.110
Why?
Aldehyde Dehydrogenase
1
2016
99
0.110
Why?
Receptor, Notch1
1
2015
64
0.110
Why?
Gene Dosage
1
2015
148
0.110
Why?
Phosphorylation
4
2019
1733
0.110
Why?
Gene Expression Regulation
1
2024
2609
0.110
Why?
Pyrazoles
1
2018
510
0.110
Why?
DNA Copy Number Variations
1
2015
183
0.110
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2014
85
0.110
Why?
Proto-Oncogene Proteins c-met
1
2014
76
0.100
Why?
Cell Cycle Proteins
1
2018
629
0.100
Why?
Protein-Tyrosine Kinases
1
2017
433
0.100
Why?
Mitogen-Activated Protein Kinases
1
2014
292
0.100
Why?
Enzyme Inhibitors
1
2016
826
0.090
Why?
Neoplasm Invasiveness
3
2020
509
0.090
Why?
Cetuximab
2
2025
111
0.090
Why?
Gene Expression Profiling
3
2024
1786
0.080
Why?
Cell Survival
3
2019
1098
0.080
Why?
Mutation
2
2018
4099
0.080
Why?
Cell Cycle
3
2018
597
0.080
Why?
Carcinogenesis
2
2024
229
0.080
Why?
Mice, Inbred NOD
2
2022
610
0.080
Why?
Phosphatidylinositol 3-Kinases
3
2018
381
0.080
Why?
RNA, Small Interfering
2
2024
635
0.080
Why?
Aged
7
2025
25947
0.070
Why?
Middle Aged
8
2025
35928
0.070
Why?
Tumor Suppressor Protein p53
2
2024
531
0.060
Why?
HCT116 Cells
2
2018
78
0.060
Why?
Microsatellite Instability
1
2025
54
0.060
Why?
Tumor Burden
2
2018
322
0.060
Why?
Angiogenesis Inhibitors
2
2018
237
0.050
Why?
Neovascularization, Pathologic
2
2018
286
0.050
Why?
Immunoblotting
2
2015
300
0.050
Why?
Proto-Oncogene Proteins c-akt
2
2018
437
0.050
Why?
Microsatellite Repeats
1
2024
157
0.050
Why?
Adult
6
2025
40506
0.050
Why?
Male
8
2025
72406
0.050
Why?
Enhancer Elements, Genetic
1
2024
192
0.050
Why?
Paclitaxel
1
2024
256
0.050
Why?
Triazoles
1
2024
184
0.050
Why?
Recombinant Fusion Proteins
1
2025
675
0.050
Why?
Ataxia Telangiectasia Mutated Proteins
1
2022
69
0.050
Why?
Organoids
1
2024
141
0.050
Why?
Histone Deacetylase 1
1
2022
23
0.050
Why?
Inflammasomes
1
2023
146
0.040
Why?
Doxorubicin
1
2024
397
0.040
Why?
Quinolines
1
2022
193
0.040
Why?
Molecular Targeted Therapy
1
2024
434
0.040
Why?
Acetylation
1
2022
256
0.040
Why?
Chimerism
1
2021
35
0.040
Why?
Immune Tolerance
1
2023
379
0.040
Why?
Lymphocyte Subsets
1
2021
83
0.040
Why?
Aminopyridines
1
2021
127
0.040
Why?
Lymphoid Tissue
1
2021
80
0.040
Why?
Membrane Proteins
2
2018
1167
0.040
Why?
Histone Deacetylases
1
2022
210
0.040
Why?
Mice, SCID
1
2021
369
0.040
Why?
Pyrroles
1
2021
218
0.040
Why?
Mechanistic Target of Rapamycin Complex 2
1
2020
63
0.040
Why?
Antimetabolites, Antineoplastic
1
2020
105
0.040
Why?
Indolizines
1
2019
13
0.040
Why?
Forkhead Box Protein M1
1
2019
8
0.040
Why?
Maximum Tolerated Dose
1
2020
212
0.040
Why?
Mechanistic Target of Rapamycin Complex 1
1
2020
139
0.040
Why?
Cell Cycle Checkpoints
1
2019
99
0.040
Why?
Genomics
1
2024
836
0.040
Why?
M Phase Cell Cycle Checkpoints
1
2018
24
0.040
Why?
Prognosis
2
2019
4293
0.040
Why?
Azetidines
1
2018
45
0.040
Why?
GTP Phosphohydrolases
1
2018
93
0.030
Why?
4-Aminobenzoic Acid
1
2018
8
0.030
Why?
HT29 Cells
1
2018
37
0.030
Why?
Aldosterone
1
2018
43
0.030
Why?
Transcription, Genetic
1
2024
1496
0.030
Why?
Drug Therapy, Combination
1
2020
1048
0.030
Why?
Antineoplastic Agents, Immunological
1
2020
199
0.030
Why?
RNA
1
2024
940
0.030
Why?
Piperidines
1
2018
217
0.030
Why?
Protein Transport
1
2018
441
0.030
Why?
Germ-Line Mutation
1
2018
175
0.030
Why?
Inhibitory Concentration 50
1
2016
91
0.030
Why?
Positron-Emission Tomography
1
2018
343
0.030
Why?
Axin Protein
1
2016
19
0.030
Why?
Histones
1
2022
670
0.030
Why?
Ubiquitination
1
2016
118
0.030
Why?
Aldehyde Dehydrogenase, Mitochondrial
1
2016
23
0.030
Why?
Protein Isoforms
1
2017
402
0.030
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2016
112
0.030
Why?
Tissue Array Analysis
1
2016
50
0.030
Why?
Sequence Analysis, RNA
1
2018
442
0.030
Why?
Neoplasm Transplantation
1
2016
252
0.030
Why?
Algorithms
1
2024
1839
0.030
Why?
Drug Screening Assays, Antitumor
1
2016
191
0.030
Why?
Gene Rearrangement
1
2017
155
0.030
Why?
Serrate-Jagged Proteins
1
2015
27
0.030
Why?
Jagged-1 Protein
1
2015
22
0.030
Why?
Gene Duplication
1
2015
67
0.030
Why?
Proto-Oncogene Proteins p21(ras)
1
2016
253
0.030
Why?
Hematopoietic Stem Cell Transplantation
1
2021
676
0.030
Why?
Diphenylamine
1
2014
8
0.030
Why?
Gene Expression Regulation, Enzymologic
1
2016
269
0.030
Why?
Neoplastic Stem Cells
1
2018
412
0.030
Why?
Calcium-Binding Proteins
1
2015
220
0.030
Why?
Class I Phosphatidylinositol 3-Kinases
1
2014
109
0.030
Why?
RNA Interference
1
2016
476
0.030
Why?
Mice, Knockout
1
2021
3125
0.030
Why?
Benzamides
1
2014
224
0.030
Why?
Intercellular Signaling Peptides and Proteins
1
2015
381
0.030
Why?
Oligonucleotide Array Sequence Analysis
1
2015
758
0.020
Why?
Transfection
1
2016
940
0.020
Why?
High-Throughput Nucleotide Sequencing
1
2017
550
0.020
Why?
Up-Regulation
1
2016
852
0.020
Why?
Phenotype
1
2021
3164
0.020
Why?
Mice, Inbred C57BL
1
2023
5997
0.020
Why?
Protein Binding
1
2018
2276
0.020
Why?
Immunohistochemistry
1
2016
1718
0.020
Why?
Models, Biological
1
2018
1822
0.020
Why?
Treatment Outcome
1
2024
11695
0.020
Why?
Transcriptome
1
2015
1046
0.020
Why?
Antibodies, Monoclonal
1
2015
1524
0.020
Why?
Magnetic Resonance Imaging
1
2018
3869
0.010
Why?
Aged, 80 and over
1
2017
8279
0.010
Why?
Bagby's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)